Article Information
History
- October 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lotus L. van den Hoogen1,*,
- Gaby Smits1,
- Cheyenne C.E. van Hagen2,
- Denise Wong2,
- Eric R.A. Vos2,
- Michiel van Boven2,
- Hester E. de Melker2,
- Jeffrey van Vliet1,
- Marjan Kuijer1,
- Linde Woudstra1,
- Alienke J. Wijmenga-Monsuur1,
- Corine H. GeurtsvanKessel3,
- Susanne P. Stoof4,
- Daphne Reukers5,
- Lisa A. Wijsman5,
- Adam Meijer5,
- Chantal B.E.M. Reusken5,
- Nynke Y. Rots1,
- Fiona R.M. van der Klis1,
- Robert S. van Binnendijk1 and
- Gerco den Hartog1
- 1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- 2Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- 3Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
- 4Department of Medical Microbiology Comicro, Dijklander ziekenhuis, Hoorn, The Netherlands
- 5Centre for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- ↵*Corresponding author: lotus.van.den.hoogen{at}rivm.nl, Centre for Immunology of Infectious Diseases and Vaccines (IIV), National Institute of Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands
Posted October 07, 2021.
Seropositivity to Nucleoprotein to detect SARS-CoV-2 infections: a tool to detect breakthrough infections after COVID-19 vaccination
